Merck and the Mectizan Donation Program Donate $1 Million to the END Fund for Efforts to Help Eliminate River Blindness in Africa
Dateline City:
KENILWORTH, N.J.
Since 1987 Merck Has Donated More than Two Billion Treatments of Mectizan to Help Eliminate River Blindness and Lymphatic Filariasis
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada,
announced today that the company, together with the Mectizan Donation
Program, is donating $1 million to the END Fund in support of efforts in
Africa to eliminate river blindness, which is also known as
onchocerciasis.
Language:
English
Contact:
For Media:Jennifer Allen Woodruff, 267-305-3550orLainie Keller, 908-236-5036orFor Investors:Teri Loxam, 908-740-1986orJustin Holko, 908-740-1879
Ticker Slug:
Ticker: MRK Exchange: NYSE
read more
Source: Merck.com - Corporate News - Category: Pharmaceuticals Tags: Corporate News Corporate Responsibility News Latest News #Merck #MRK $MRK END Fund Mectizan NYSE:MRK River Blindness Source Type: news
More News: African Health | Blindness | Filariasis | Merck | Opthalmology | Pharmaceuticals | River Blindness